|
|
|
Volumn 28, Issue 3, 2010, Pages 102-103
|
|
Denosumab: New treatment possibility for the prevention of bone loss;Denosumab: Neue behandlungsmöglichkeit zur prävention von knochenabbau
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DENOSUMAB;
OSTEOCLAST DIFFERENTIATION FACTOR;
PLACEBO;
PROLIA;
TOREMIFENE;
UNCLASSIFIED DRUG;
ZOLEDRONIC ACID;
ANTIANDROGEN THERAPY;
BONE DENSITOMETRY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG MECHANISM;
FEMALE;
FRACTURE;
FRACTURE NONUNION;
HUMAN;
INFECTION;
INJECTION SITE REACTION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NEOPLASM;
NOTE;
OSTEOPOROSIS;
POSTMENOPAUSE OSTEOPOROSIS;
PROPHYLAXIS;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT DURATION;
|
|
EID: 77953468287
PISSN: 07236913
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
